# Study of Harmine in Healthy Subjects

> **NCT05526430** · PHASE1 · COMPLETED · sponsor: **James Murrough** · enrollment: 27 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Harmine Hydrochloride Capsules

## Key facts

- **NCT ID:** NCT05526430
- **Lead sponsor:** James Murrough
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-13
- **Primary completion:** 2023-06-23
- **Final completion:** 2023-06-23
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05526430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05526430, "Study of Harmine in Healthy Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05526430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*